Stimuli-Responsive Drug Delivery Systems for Neurological, Cardiovascular, and Metabolic Disorders: Pharmacological Triggers and Therapeutic Applications
International Journal of Drug Delivery Technology · 09.06.2026 · 16 (51s)
DOI: 10.25258/ijddt.16.51s.26 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 09.06.2026. Verfasst von Anurag Singh und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Stimuli-responsive drug delivery systems (SRDDs) represent a paradigm shift in drug formulation strategies, moving from static formulation design to dynamic formulation architecture based on pathophysiology. SRDDs exploit diseasespecific microenvironmental stimuli to enhance therapeutic and pharmacokinetic outcomes compared to conventional delivery system. BBB obstructs more than 98% of substances in CNS, atherosclerotic plaque creates enzyme-rich, oxidatively stressed microenvironments largely inaccessible in CVS, and the oscillating insulin kinetics in diabetes requires novel drug delivery systems like SRDD to overcome these limitations. SRDD carriers are designed to trigger drug release by a physicochemical change in the presence of biomarkers, such as oxidative biomarkers, matrix metalloproteinases (MMPs), pH gradients, glucose concentration, hemodynamic shearstress, hypoxia, and temperature deviation, at the pathological sites and in a particular time. Oxidative stress responsiveness is universal among SRDDs, their structural designs, carrier platforms, and cargoes are disease-modified. SRDDs improve therapeutic indices and plasma half-life, and their pharmacokinetics can be tailored to biological demand. Emerging multi-stimuli-responsive platforms and AI- driven formulation optimisation further advance SRDD translational potential. Therefore, SRDDs signify a comprehensive and promising pharmacological approach for clinical and personalised medicine.
Zitieren
APA
Singh, A., Gupta, A. K., Verma, H., Yadav, R., Verma, N., Yadav, J., Mishra, S., Mishra, A. K., & Katiyar, P. (2026). Stimuli-Responsive Drug Delivery Systems for Neurological, Cardiovascular, and Metabolic Disorders: Pharmacological Triggers and Therapeutic Applications. International Journal of Drug Delivery Technology, 16(51s). https://doi.org/10.25258/ijddt.16.51s.26
Vancouver
Singh A, Gupta AK, Verma H, Yadav R, Verma N, Yadav J, et al. Stimuli-Responsive Drug Delivery Systems for Neurological, Cardiovascular, and Metabolic Disorders: Pharmacological Triggers and Therapeutic Applications. International Journal of Drug Delivery Technology. 2026;16(51s). doi:10.25258/ijddt.16.51s.26
BibTeX
@article{Singh2026,
author = {Singh, Anurag and Gupta, Ajay Kumar and Verma, Harshita and Yadav, Ratan and Verma, Noopur and Yadav, Jyoti and Mishra, Sameer and Mishra, Anurag Kumar and Katiyar, Praveen},
title = {Stimuli-Responsive Drug Delivery Systems for Neurological, Cardiovascular, and Metabolic Disorders: Pharmacological Triggers and Therapeutic Applications},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {51s},
doi = {10.25258/ijddt.16.51s.26}
}
EUVIMED